Beneficial effects of the Mediterranean diet on metabolic syndrome

Current Pharmaceutical Design

Volumn 20, Issue 31, 2014, Pages 5039-5044

  Grosso, Giuseppe ^a   Mistretta, Antonio ^a   Marventano, Stefano ^a   Purrello, Agata ^a   Vitaglione, Paola ^b   Calabrese, Giorgio ^c   Drago, Filippo ^a   Galvano, Fabio ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Cardiovascular disease; Chronic disease; Mediterranean diet; Metabolic syndrome; Prevention

Indexed keywords

BODY WEIGHT; CARDIOVASCULAR RISK; DIETARY COMPLIANCE; HUMAN; HYPERTENSION; MEDITERRANEAN DIET; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; DIET THERAPY; INCIDENCE; ABDOMINAL OBESITY; ARTICLE; DIETARY INTAKE; DYSLIPIDEMIA; EPIDEMIC; HYPERGLYCEMIA; PATIENT COMPLIANCE; TREATMENT REFUSAL;

DIET, MEDITERRANEAN; HUMANS; INCIDENCE; METABOLIC SYNDROME X; PREVALENCE;

EID: 84906235864     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612819666131206112144     Document Type: Review

References (97)

1. World Health Organization. Active ageing: a policy framework. 2009. Available from: http: //whqlibdoc.who.int/hq/2002/who_nmh_nph_02.8.pdf. [Accessed: 22/01/2013]
2. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952.
3. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
4. Obunai K, Jani S, Dangas GD. Cardiovascular morbidity and mortality of the metabolic syndrome. Med Clin North Am 2007; 91: 1169-1184.
5. Grundy SM, Hansen B, Smith SC, Jr., et al. Clinical management of metabolic syndrome: report of the American Heart Association, National Heart, Lung, and Blood Institute, American Diabetes Association conference on scientific issues related to management. Circulation 2004; 109: 551-556.
6. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome--a new worldwide definition. Lancet 2005; 366: 1059-1062.
7. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
8. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
9. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
10. Park HS, Kim SM, Lee JS, et al. Prevalence and trends of metabolic syndrome in Korea: Korean National Health and Nutrition Survey 1998-2001. Diabetes Obes Metab 2007; 9: 50-58.
11. Hu G, Qiao Q, Tuomilehto J, et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004; 164: 1066-1076.
12. Athyros VG, Bouloukos VI, Pehlivanidis AN, et al. The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study. Diabetes Obes Metab 2005; 7: 397-405.
13. Miccoli R, Bianchi C, Odoguardi L, et al. Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr Metab Cardiovasc Dis 2005; 15: 250-254.
14. Maggi S, Noale M, Gallina P, et al. Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging J Gerontol. A Biol Sci Med Sci 2006; 61: 505-510.
15. Santos AC, Lopes C, Barros H. Prevalence of metabolic syndrome in the city of Porto. Rev Port Cardiol 2004; 23: 45-52.
16. Athyros VG, Ganotakis ES, Tziomalos K, et al. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Curr Med Res Opin 2010; 26: 713-719.
17. Lioudaki E, Vrentzos GE, Mavrogeni H, et al. Prevalence of metabolic syndrome according to different definitions in a hypertensive population. Angiology 2012; 63: 39-47.
18. Corrado E, Rizzo M, Caccamo G, et al. Prevalence of metabolic syndrome: a comparative analysis in an unselected sample of mediterranean subjects. Int Angiol 2012; 31: 572-578.
19. Kesteloot H, Sans S, Kromhout D. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J 2006; 27: 107-113.
20. de LM, Salen P. Modified cretan Mediterranean diet in the prevention of coronary heart disease and cancer: An update World Rev. Nutr Diet 2007; 97: 1-32.
21. Keys A, Menotti A, Karvonen MJ, et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol 1986; 124: 903-915.
22. Keys A, Aravanis C, Blackburn HW, et al. Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. Acta Med Scand. Suppl 1966; 460: 1-392.
23. Sanchez-Tainta A, Estruch R, Bullo M, et al. Adherence to a Mediterranean-type diet and reduced prevalence of clustered cardiovascular risk factors in a cohort of 3,204 high-risk patients. Eur J Car-diovasc Prev Rehabil 2008; 15: 589-593.
24. Tortosa A, Bes-Rastrollo M, Sanchez-Villegas A, et al. Mediterranean diet inversely associated with the incidence of metabolic syndrome: the SUN prospective cohort. Diabetes Care 2007; 30: 2957-2959.
25. Babio N, Bullo M, Basora J, et al. Adherence to the Mediterranean diet and risk of metabolic syndrome and its components. Nutr Me-tab Cardiovasc Dis 2009; 19: 563-570.
26. Kesse-Guyot E, Ahluwalia N, Lassale C, et al. Adherence to Mediterranean diet reduces the risk of metabolic syndrome: A 6-year prospective study. Nutr Metab Cardiovasc Dis 2013; 23: 677-683.
27. Paletas K, Athanasiadou E, Sarigianni M, et al. The protective role of the Mediterranean diet on the prevalence of metabolic syndrome in a population of Greek obese subjects. J Am Coll Nutr 2010; 29: 41-45.
28. Landaeta-Diaz L, Fernandez JM, Da Silva-Grigoletto M, et al. Mediterranean diet, moderate-to-high intensity training and health-related quality of life in adults with metabolic syndrome. Eur J Prev Cardiol 2013; 20: 555-564.
29. Gouveri ET, Tzavara C, Drakopanagiotakis F, et al. Mediterranean diet and metabolic syndrome in an urban population: the Athens Study. NutrClinPract 2011; 26: 598-606.
30. Rumawas ME, Meigs JB, Dwyer JT, et al. Mediterranean-style dietary pattern, reduced risk of metabolic syndrome traits, and incidence in the Framingham Offspring Cohort. Am J Clin Nutr 2009; 90: 1608-1614.
31. Thanopoulou A, Karamanos B, Angelico F, et al. Epidemiological evidence for the non-random clustering of the components of the metabolic syndrome: multicentre study of the Mediterranean Group for the Study of Diabetes. Eur J Clin Nutr 2006; 60: 1376-1383.
32. Alvarez Leon EE, Henriquez P, Serra-Majem L. Mediterranean diet and metabolic syndrome: a cross-sectional study in the Canary Islands. Public Health Nutr 2006; 9: 1089-1098.
33. Tzima N, Pitsavos C, Panagiotakos DB, et al. Mediterranean diet and insulin sensitivity, lipid profile and blood pressure levels, in overweight and obese people; the Attica study. Lipids Health Dis 2007; 6: 22.
34. Richard C, Couture P, Desroches S, et al. Effect of the Mediterranean Diet With and Without Weight Loss on Markers of Inflammation in Men With Metabolic Syndrome. Obesity (Silver. Spring) 2013; 21: 51-57.
35. Mitjavila MT, Fandos M, Salas-Salvado J, et al. The Mediterranean diet improves the systemic lipid and DNA oxidative damage in metabolic syndrome individuals. A randomized, controlled, trial. Clin Nutr 2013; 32: 172-178.
36. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. The epidemiology of Type 2 diabetes mellitus in Greek adults: the ATTICA study. Diabet Med 2005; 22: 1581-1588.
37. Panagiotakos DB, Tzima N, Pitsavos C, et al. The association between adherence to the Mediterranean diet and fasting indices of glucose homoeostasis: the ATTICA Study. J Am Coll Nutr 2007; 26: 32-38.
38. Esposito K, Maiorino MI, Di PC, et al. Adherence to a Mediterranean diet and glycaemic control in Type 2 diabetes mellitus. Diabet Med 2009; 26: 900-907.
39. Carter SJ, Roberts MB, Salter J, et al. Relationship between Mediterranean Diet Score and atherothrombotic risk: findings from the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. Atherosclerosis 2010; 210: 630-636.
40. Panagiotakos DB, Chrysohoou C, Pitsavos C, et al. Association between the prevalence of obesity and adherence to the Mediterranean diet: the ATTICA study. Nutrition 2006; 22: 449-456.
41. Yannakoulia M, Panagiotakos D, Pitsavos C, et al. Five-year incidence of obesity and its determinants: the ATTICA study. Public Health Nutr 2009; 12: 36-43.
42. Tyrovolas S, Bountziouka V, Papairakleous N, et al. Adherence to the Mediterranean diet is associated with lower prevalence of obesity among elderly people living in Mediterranean islands: the MEDIS study. Int J Food Sci Nutr 2009; 1-14.
43. Trichopoulou A, Orfanos P, Norat T, et al. Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ 2005; 330: 991.
44. Romaguera D, Norat T, Vergnaud AC, et al. Mediterranean dietary patterns and prospective weight change in participants of the EPIC-PANACEA project. Am J Clin Nutr 2010; 92: 912-921.
45. Mendez MA, Popkin BM, Jakszyn P, et al. Adherence to a Mediterranean diet is associated with reduced 3-year incidence of obesity. J Nutr 2006; 136: 2934-2938.
46. Romaguera D, Norat T, Mouw T, et al. Adherence to the Mediterranean diet is associated with lower abdominal adiposity in European men and women. J Nutr 2009; 139: 1728-1737.
47. Schroder H, Marrugat J, Vila J, et al. Adherence to the traditional mediterranean diet is inversely associated with body mass index and obesity in a spanish population. J Nutr 2004; 134: 3355-3361.
48. Sanchez-Villegas A, Bes-Rastrollo M, Martinez-Gonzalez MA, et al. Adherence to a Mediterranean dietary pattern and weight gain in a follow-up study: the SUN cohort. Int J Obes (Lond) 2006; 30: 350-358.
49. Rossi M, Negri E, Bosetti C, et al. Mediterranean diet in relation to body mass index and waist-to-hip ratio. Public Health Nutr 2008; 11: 214-217.
50. Woo J, Cheung B, Ho S, et al. Influence of dietary pattern on the development of overweight in a Chinese population. Eur J Clin Nutr 2008; 62: 480-487.
51. Shubair MM, McColl RS, Hanning RM. Mediterranean dietary components and body mass index in adults: the peel nutrition and heart health survey. Chronic Dis Can 2005; 26: 43-51.
52. Nunez-Cordoba JM, Valencia-Serrano F, Toledo E, et al. The Mediterranean diet and incidence of hypertension: the Seguimiento Universidad de Navarra (SUN) Study. Am J Epidemiol 2009; 169: 339-346.
53. Masala G, Bendinelli B, Versari D, et al. Anthropometric and dietary determinants of blood pressure in over 7000 Mediterranean women: the European Prospective Investigation into Cancer and Nutrition-Florence cohort. J Hypertens. 2008; 26: 2112-2120.
54. Psaltopoulou T, Naska A, Orfanos P, et al. Olive oil, the Mediterranean diet, and arterial blood pressure: the Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr 2004; 80: 1012-1018.
55. Lairon D. Intervention studies on Mediterranean diet and cardiovascular risk. MolNutr Food Res 2007; 51: 1209-1214.
56. Tyrovolas S, Panagiotakos DB. The role of Mediterranean type of diet on the development of cancer and cardiovascular disease, in the elderly: a systematic review. Maturitas 2010; 65: 122-130.
57. Riccioni G, Bucciarelli T, Mancini B, et al. Antioxidant vitamin supplementation in cardiovascular diseases. Ann Clin Lab Sci 2007; 37: 89-95.
58. Riccioni G. Carotenoids and cardiovascular disease. CurrAtheros-clerRep 2009; 11: 434-439.
59. Stoclet JC, Chataigneau T, Ndiaye M, et al. Vascular protection by dietary polyphenols. Eur J Pharmacol 2004; 500: 299-313.
60. Giugliano D. Dietary antioxidants for cardiovascular prevention. NutrMetabCardiovasc Dis 2000; 10: 38-44.
61. Maron DJ. Flavonoids for reduction of atherosclerotic risk. CurrA-theroscler Rep 2004; 6: 73-78.
62. Van Herpen-Broekmans WM, Klopping-Ketelaars IA, Bots ML, et al. Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation. Eur J Epidemiol 2004; 19: 915-921.
63. Brighenti F, Valtuena S, Pellegrini N, et al. Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of high-sensitivity C-reactive protein in adult Italian subjects. Br J Nutr 2005; 93: 619-625.
64. Fardet A. New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?. Nutr Res Rev 2010; 23: 65-134.
65. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000; 92: 1472-1489.
66. Laaksonen DE, Toppinen LK, Juntunen KS, et al. Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome. Am J Clin. Nutr 2005; 82: 1218-1227.
67. Price RK, Keaveney EM, Hamill LL, et al. Consumption of wheat aleurone-rich foods increases fasting plasma betaine and modestly decreases fasting homocysteine and LDL-cholesterol in adults. J Nutr 2010; 140: 2153-2157.
68. Aguilera CM, Ramirez-Tortosa MC, Mesa MD, et al. Protective effect of monounsaturated and polyunsaturated fatty acids on the development of cardiovascular disease. NutrHosp 2001; 16: 78-91.
69. Gopinath B, Buyken AE, Flood VM, et al. Consumption of polyun-saturated fatty acids, fish, and nuts and risk of inflammatory disease mortality. Am J Clin Nutr 2011; 93: 1073-1079.
70. Calder PC, Yaqoob P. Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques. Cell MolBiol (Noisy. -le-grand) 2010; 56: 28-37.
71. Lee JH, O'Keefe JH, Lavie CJ, et al. Omega-3 fatty acids: cardiovascular benefits, sources and sustainability. Nat Rev Cardiol 2009; 6: 753-758.
72. Trichopoulou A, Dilis V. Olive oil and longevity. MolNutrFood Res 2007; 51: 1275-1278.
73. Esposito K, Marfella R, Ciotola M, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004; 292: 1440-1446.
74. Covas MI. Olive oil and the cardiovascular system. Pharmacol Res 2007; 55: 175-186.
75. Kelly JH, Jr., Sabate J. Nuts and coronary heart disease: an epide-miological perspective. Br J Nutr 2006; 96 Suppl 2: S61-S67.
76. Salas-Salvado J, Fernandez-Ballart J, Ros E, et al. Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. Arch Intern Med 2008; 168: 2449-2458.
77. Jenkins DJ, Kendall CW, Josse AR, et al. Almonds decrease postprandial glycemia, insulinemia, and oxidative damage in healthy individuals. J Nutr 2006; 136: 2987-2992.
78. Josse AR, Kendall CW, Augustin LS, et al. Almonds and postprandial glycemia--a dose-response study. Metabolism 2007; 56: 400-404.
79. Jonsson T, Granfeldt Y, Ahren B, et al. Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study. CardiovascDiabetol 2009; 8: 35.
80. Casas-Agustench P, Lopez-Uriarte P, Bullo M, et al. Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome. NutrMetabCardiovascDis 2011; 21: 126-135.
81. Fernandez-Montero A, Bes-Rastrollo M, Beunza JJ, et al. Nut consumption and incidence of metabolic syndrome after 6-year follow-up: the SUN (Seguimiento Universidad de Navarra, University of Navarra Follow-up) cohort. Public HealthNutr 2012; 1-9.
82. O'Neil CE, Keast DR, Nicklas TA, et al. Nut consumption is associated with decreased health risk factors for cardiovascular disease and metabolic syndrome in U.S. adults: NHANES 1999-2004. J Am CollNutr 2011; 30: 502-510.
83. Rosell M, De FU, Hellenius ML. Low prevalence of the metabolic syndrome in wine drinkers--is it the alcohol beverage or the lifestyle?. Eur J Clin Nutr 2003; 57: 227-234.
84. Pellegrini N, Pareti FI, Stabile F, et al. Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers. Eur J Clin Nutr 1996; 50: 209-213.
85. Bradamante S, Barenghi L, Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 2004; 22: 169-188.
86. Corder R, Mullen W, Khan NQ, et al. Oenology: red wine procya-nidins and vascular health. Nature 2006; 444: 566.
87. Hammerstone JF, Lazarus SA, Schmitz HH. Procyanidin content and variation in some commonly consumed foods. J Nutr 2000; 130: 2086S-2092S.
88. Hu T, Mills KT, Yao L, et al. Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol 2012; 176 Suppl 7: 44-54.
89. Jans A, Van Hees AM, Gjelstad IM, et al. Impact of dietary fat quantity and quality on skeletal muscle fatty acid metabolism in subjects with the metabolic syndrome. Metabolism 2012; 61: 1554-1565.
90. Lefevre M, Champagne CM, Tulley RT, et al. Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol. Am J Clin Nutr 2005; 82: 957-963.
91. Garg A. High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 1998; 67: 577S-582S.
92. Cao Y, Mauger DT, Pelkman CL, et al. Effects of moderate (MF) versus lower fat (LF) diets on lipids and lipoproteins: a meta-analysis of clinical trials in subjects with and without diabetes. J ClinLipidol 2009; 3: 19-32.
93. Athyros VG, Elisaf MF, Alexandrides T, et al. Assessing the Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative Group. Long-term impact of mul-tifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis. Angiology 2012; 63: 358-366.
94. Athyros VG, Ganotakis E, Kolovou GD, et al. Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative. Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women. Curr Vasc Pharmacol 2011; 9: 647-657.
95. Athyros VG, Karagiannis A, Hatzitolios AI, et al. Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study. Curr Med Res Opin 2009; 25: 971-980.
96. Athyros VG, Karagiannis A, Ganotakis ES, et al. Assessing The Treatment Effect in Metabolic syndrome without Perceptible diabeTes (ATTEMPT) Collaborative Group. Association between the changes in renal function and serum uric acid levels during multi-factorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study. Curr Med Res Opin 2011; 27: 1659-1668.
97. Athyros VG, Giouleme O, Ganotakis ESEM, et al. Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study. Arch Med Sci 2011; 7: 796-805.